The national budget impact of managed entry agreement strategies match with high-cost drugs to maximise drug cost saving: a study protocol
The rationales for each MEA technique selection are similar across their objectives. MEA can help reduce drug expenditures. Therefore, the budget in health care system could be sustainable and the patient access to high-cost drug could be increased. However, it might not be suitable for some circumstances and should not be implemented to determine drug price or used as regular reimbursement.
Authors
- Tuangrat Phodha (ORCID: https://orcid.org/0000-0001-7793-0327)
- Hataiwan Ratanabunjerdkul (ORCID: https://orcid.org/0009-0008-2129-2221)
- Chaoncin Sooksriwong (ORCID: https://orcid.org/0000-0002-6188-882X)
- Piyapat Owat (ORCID: https://orcid.org/0009-0001-1595-6123)
Institutions
- Thammasat University (TH)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1080/20523211.2024.2428395
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Thammasat University